About Conjupro Biotherapeutics
Conjupro Biotherapeutics is a private company based in Princeton, New Jersey. It has reported $9,321,686 raised in one offering on Form D since September 2023. Its chief executive is Qingxi Wang.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 1, 2023 | Sep 12, 2023 | $9,321,686of $67.4M target | 1 | $9.3M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Conjupro Biotherapeutics's Form D filed Sep 12, 2023.
HW
Haixing Wang
Executive officer
QW
Qingxi Wang
CEO and director